Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02027571 · ClinicalTrials.gov registry record · NA
Pathobiology and Reversibility of Prediabetes in a Biracial Cohort
A NA study, sponsored by University of Tennessee.
- Completed
- Registry status
- NA
- Development phase
- 223
- Enrollment target
NCT02027571 is a NA study that has completed, run by University of Tennessee. The registered enrollment target is 223 participants.
The verdict
NCT02027571, a NA study, has completed, sponsored by University of Tennessee.
- COMPLETED
- Registry status
- NA
- Development phase
- 223 participants
- Enrollment target
Study Summary
The reasons for the epidemics of diabetes and prediabetes, and why individuals from certain populations suffer at higher rates are not well known. In the Pathobiology and Reversibility of Prediabetes in a Biracial Cohort (PROP-ABC) study, nearly 400 African Americans and Caucasians whose parents have type 2 diabetes will undergo repeated testing to determine what factors lead to the occurrence of prediabetes, and whether race still plays a major role in a setting where everyone being studied has one or both parents with diabetes. The PROP-ABC Study also will test the hypothesis that the ability of intensive lifestyle intervention to reverse prediabetes and return people's metabolism back to normal is dependent on how long people have had prediabetes.
Interventions
- BEHAVIORAL Intensive Lifestyle Intervention (ILI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 223 participants |
| Start Date | 2013-10 |
| Est. Completion | 2018-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02027571
The ClinicalTrials.gov registry entry for NCT02027571 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 223 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Tennessee, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intensive Lifestyle Intervention (ILI) is the first listed.
NCT02027571 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02027571 about?
NCT02027571 is a clinical study titled "Pathobiology and Reversibility of Prediabetes in a Biracial Cohort". The reasons for the epidemics of diabetes and prediabetes, and why individuals from certain populations suffer at higher rates are not well known. In the Pathobiology and Reversibility of Prediabetes in a Biracial Cohort (PROP-ABC) study, nearly 400 African Americans and Caucasians whose parents hav...
What is the current status of trial NCT02027571?
This trial is currently completed. It is a NA study. The enrollment target is 223 participants. The study started on 2013-10. Estimated completion is 2018-10.
What interventions are being tested in trial NCT02027571?
The interventions under investigation include: Intensive Lifestyle Intervention (ILI) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02027571?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.